Harbin Pharmaceutical Group (600664.SH): Ferrous Protein Succinate obtains approval notice for chemical raw materials drug market application.
Haiyao Group Co., Ltd. (600664.SH) announced recently that its subsidiary, Ha Yao Group San Jing Ming Shui Pharmaceuticals Co., Ltd., has received the "Notice of Approval for the Market Application of Ferrous Succinate" from the National Medical Products Administration of China, with the document number 2026YS00100.
Harbin Pharmaceutical Group (600664.SH) announced that recently, its subsidiary, Ha Yao Group Sanjing Ming Shui Pharmaceutical Co., Ltd., received the "Chemical Raw Material Drug Market Approval Notification" for Ferrous Sucrose issued by the National Medical Products Administration [Number: 2026YS00100].
The approval of Ferrous Sucrose as a chemical raw material drug is an important development for the company in the field of raw materials, as it will allow the company to have independent control over related raw materials. At the same time, this approval will further solidify the company's integrated development strategy for raw material formulations, and will enrich the company's product structure.
Related Articles
LUEN THAI (00311) Announces Profit Growth, Expected to reach a net profit of approximately 3.8 to 4.8 million US dollars in 2025, reversing from a loss to a profit compared to the previous year.
Jiangsu Hengrui Pharmaceuticals(600276.SH): The market approval application for HR091506 tablets has been accepted by the National Medical Products Administration.
TRUE PARTNER (08657) issues profit warning, projecting that the annual comprehensive loss attributable to shareholders will decrease by no less than 30% significantly.
LUEN THAI (00311) Announces Profit Growth, Expected to reach a net profit of approximately 3.8 to 4.8 million US dollars in 2025, reversing from a loss to a profit compared to the previous year.
Jiangsu Hengrui Pharmaceuticals(600276.SH): The market approval application for HR091506 tablets has been accepted by the National Medical Products Administration.
TRUE PARTNER (08657) issues profit warning, projecting that the annual comprehensive loss attributable to shareholders will decrease by no less than 30% significantly.
